Regulated GPCR traf ficking to the plasma membrane: General issues and the CCR5 chemokine receptor example

Subcellular Biochemistry

Volumn 63, Issue , 2012, Pages 97-111

  Shirvani, Hamasseh ^a,b   Gätà, Gabriel ^a,b   Marullo, Stefano ^a,b  

^a INSTITUT COCHIN   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

CCR5; CD4; Chaperone; Escort protein; Gate keeper; GPCR; Resensitization; Secretory pathway

Indexed keywords

CHAPERONE; CHEMOKINE RECEPTOR CCR5; G PROTEIN COUPLED RECEPTOR;

ANIMAL; CELL MEMBRANE; HUMAN; METABOLISM; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL MEMBRANE; HUMANS; MOLECULAR CHAPERONES; PROTEIN TRANSPORT; RECEPTORS, CCR5; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84885917502     PISSN: 03060225     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-4765-4_6     Document Type: Article

References (67)

1. Achour L, Scott MG, Shirvani H, Thuret A, Bismuth G, Labbe-Jullie C, Marullo S (2009) CD4-CCR5 interaction in intracellular compartments contributes to receptor expression at the cell surface. Blood 113: 1938-1947.
2. Alexander B, Warner-Schmidt J, Eriksson T, Tamminga C, Arango-Llievano M, Ghose S, Vernov M, Stavarche M, Musatov S, Flajolet M, Svenningsson P, Greengard P, Kaplitt MG (2010) Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens. Sci Transl Med 2: 76.
3. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA (1996) CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272(5270): 1955-1958.
4. Aramori I, Ferguson SS, Bieniasz PD, Zhang J, Cullen B, Cullen MG (1997) Molecular mechanism of desensitization of the chemokine receptor CCR-5: receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor. EMBO J 16(15): 4606-4616.
5. Baker EK, Colley NJ, Zuker CS (1994) The cyclophilin homolog NinaA functions as a chaperone, forming a stable complex in vivo with its protein target rhodopsin. EMBO J 13(20): 4886-4895.
6. Beetz C, Schule R, Deconinck T, Tran-Viet KN, Zhu H, Kremer BP, Frints SG, van Zelst-Stams WA, Byrne P, Otto S, Nygren AO, Baets J, Smets K, Ceulemans B, Dan B, Nagan N, Kassubek J, Klimpe S, Klopstock T, Stolze H, Smeets HJ, Schrander-Stumpel CT, Hutchinson M, van de Warrenburg BP, Braastad C, Deufel T, Pericak-Vance M, Schols L, de Jonghe P, Zuchner S (2008) REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31. Brain 131(Pt 4): 1078-1086.
7. Behrens M, Bartelt J, Reichling C, Winnig M, Kuhn C, Meyerhof W (2006) Members of RTP and REEP gene families influence functional bitter taste receptor expression. J Biol Chem 281(29): 20650-20659.
8. Benkirane M, Jin DY, Chun RF, Koup RA, Jeang KT (1997) Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32. J Biol Chem 272(49): 30603-30606.
9. Bermak JC, Li M, Bullock C, Zhou QY (2001) Regulation of transport of the dopamine D1 receptor by a new membrane-associated ER protein. Nat Cell Biol 3(5): 492-498.
10. Bernier V, Bichet DG, Bouvier M (2004) Pharmacological chaperone action on G-protein-coupled receptors. Curr Opin Pharmacol 4(5): 528-533.
11. Bouschet T, Martin S, Henley JM (2005) Receptor-activity-modifying proteins are required for forward trafficking of the calcium-sensing receptor to the plasma membrane. J Cell Sci 118(Pt 20): 4709-4720.
12. Brismar H, Asghar M, Carey RM, Greengard P, Aperia A (1998) Dopamine-induced recruitment of dopamine D1 receptors to the plasma membrane. Proc Natl Acad Sci U S A 95(10): 5573-5578.
13. Chen Y, Chen C, Kotsikorou E, Lynch DL, Reggio PH, Liu-Chen LY (2009) GEC1-Kappa opioid receptor binding involves hydrophobic interactions: GEC1 has chaperone-like effect. J Biol Chem 284: 1673-1685.
14. Christopoulos A, Christopoulos G, Morfis M, Udawela M, Laburthe M, Couvineau A, Kuwasako K, Tilakaratne N, Sexton PM (2003) Novel receptor partners and function of receptor activitymodifying proteins. J Biol Chem 278(5): 3293-3297.
15. Couve A, Filippov AK, Connolly CN, Bettler B, Brown DA, Moss SJ (1998) Intracellular retention of recombinant GABAB receptors. J Biol Chem 273(41): 26361-26367.
16. Decaillot FM, Rozenfeld R, Gupta A, Devi LA (2008) Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4. Proc Natl Acad Sci U S A 105(41): 16045-16050.
17. Del Corno M, Liu QH, Schols D, de Clercq E, Gessani S, Freedman BD, Collman RG (2001) HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calcium-dependent, pertussis toxin-insensitive chemokine receptor signaling. Blood 98(10): 2909-2916.
18. Ding Z, Issekutz TB, Downey GP, Waddell TK (2003) L-selectin stimulation enhances functional expression of surface CXCR4 in lymphocytes: implications for cellular activation during adhesion and migration. Blood 101: 4245-4252.
19. Donato R (1999) Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta 1450(3): 191-231.
20. Dong C, Filipeanu CM, Duvernay MT, Wu G (2007) Regulation of G protein-coupled receptor export trafficking. Biochim Biophys Acta 1768(4): 853-870.
21. Doyle C, Strominger JL (1987) Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature 330(6145): 256-259.
22. Dwyer ND, Troemel ER, Sengupta P, Bargmann CI (1998) Odorant receptor localization to olfactory cilia is mediated by ODR-4, a novel membrane-associated protein. Cell 93(3): 455-466.
23. Escola JM, Kuenzi G, Gaertner H, Foti M, Hartley O (2010) CC chemokine receptor 5 (CCR5) desensitization: cycling receptors accumulate in the trans-Golgi network. J Biol Chem 285: 41772-41780.
24. Ferreira PA, Nakayama TA, Pak WL, Travis GH (1996) Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. Nature 383(6601): 637-640.
25. Ge X, Loh HH, Law PY (2009) m-Opioid receptor cell surface expression is regulated by its direct interaction with ribophorin I. Mol Pharmacol 75: 1307-1316.
26. Gimelbrant AA, Stoss TD, Landers TM, McClintoc TS (1999) Truncation releases olfactory receptors from the endoplasmic reticulum of heterologous cells. J Neurochem 72: 2301-2311.
27. Guglielmi L, Gimenez S, Larroque M, Tong X, Portalès P, Corbeau P (2011) Circulating human CD4+ T cells have intracellular pools of CCR5 molecules. Blood 118: 1177-1178.
28. He J, Bellini M, Xu J, Castleberry AM, Hall RA (2004) Interaction with cysticfibrosis transmembrane conductance regulator-associated ligand (CAL) inhibits beta1-adrenergic receptor surface expression. J Biol Chem 279: 50190-50196.
29. Hein L, Ishii K, Coughlin SR, Kobilka BK (1994) Intracellular targeting and trafficking of thrombin receptors. A novel mechanism for resensitization of a G protein-coupled receptor. J Biol Chem 269: 27719-27726.
30. Holtback U, Brismar H, DiBona GF, Fu M, Greengard P, Aperia A (1999) Receptor recruitment: a mechanism for interactions between G protein-coupled receptors. Proc Natl Acad Sci U S A 96(13): 7271-7275.
31. Hukovic N, Rocheville M, Kumar U, Sasi R, Khare S, Patel YC (1999) Agonist-dependent upregulation of human somatostatin receptor type 1 requires molecular signals in the cytoplasmic C-tail. J Biol Chem 274: 24550-24558.
32. Ikebuchi Y, Takada T, Ito K, Yoshikado T, Anzai N, Kanai Y, Suzuki H (2009) Receptor for activated C-kinase 1 regulates the cellular localization and function of ABCB4. Hepatol Res 39: 1091-1107.
33. Jones KA, Borowsky B, Tamm JA, Craig DA, Durkin MM, Dai M, Yao WJ, Johnson M, Gunwaldsen C, Huang LY, Tang C, Shen Q, Salon JA, Morse K, Laz T, Smith KE, Nagarathnam D, Noble SA, Branchek TA, Gerald C (1998) GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature 396(6712): 674-679.
34. Kaupmann K, Malitschek B, Schuler V, Heid J, Froestl W, Beck P, Mosbacher J, Bischoff S, Kulik A, Shigemoto R, Karschin A, Bettler B (1998) GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature 396: 683-687.
35. Leclerc PC, Auger-Messier M, Lanctot PM, Escher E, Leduc R, Guillemette G (2002) A polyaromatic caveolin-binding-like motif in the cytoplasmic tail of the type 1 receptor for angiotensin II plays an important role in receptor trafficking and signaling. Endocrinology 143(12): 4702-4710.
36. Lin YL, Mettling C, Portales P, Rouzier R, Clot J, Reynes J, Corbeau P (2008) The chemokine CCL5 regulates the in vivo cell surface expression of its receptor, CCR5. AIDS 22(3): 430-432.
37. Loconto J, Papes F, Chang E, Stowers L, Jones EP, Takada T, Kumanovics A, Fischer Lindahl K, Dulac C (2003) Functional expression of murine V2R pheromone receptors involves selective association with the M10 and M1 families of MHC class Ib molecules. Cell 112(5): 607-618.
38. Luo W, Wang Y, Reiser G (2007) p24A, A type I transmembrane protein, controls ARF1-dependent resensitization of protease-activated receptor-2 by influence on receptor trafficking. J Biol Chem 282(41): 30246-30255.
39. Luo W, Wang Y, Reiser G (2011) Proteinase-activated receptors, nucleotide P2Y receptors, and m-opioid receptor-1B are under the control of the type I transmembrane proteins p23 and p24A in post-Golgi trafficking. J Neurochem 117: 71-81.
40. Margeta-Mitrovic M, Jan YN, Jan LY (2000) A trafficking checkpoint controls GABA(B) receptor heterodimerization. Neuron 27(1): 97-106.
41. McClintock TS, Landers TM, Gimelbrant AA, Fuller LZ, Jackson BA, Jayawickreme CK, Lerner MR (1997) Functional expression of olfactory-adrenergic receptor chimeras and intracellular retention of heterologously expressed olfactory receptors. Brain Res Mol Brain Res 48: 270-278.
42. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393(6683): 333-339.
43. Metherell LA, Chapple JP, Cooray S, David A, Becker C, Ruschendorf F, Naville D, Begeot M, Khoo B, Nurnberg P, Huebner A, Cheetham ME, Clark AJ (2005) Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nat Genet 37(2): 166-170.
44. Morello JP, Salahpour A, Laperriere A, Bernier V, Arthus MF, Lonergan M, Petaja-Repo U, Angers S, Morin D, Bichet DG, Bouvier M (2000) Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Invest 105(7): 887-895.
45. Muff R, Buhlmann N, Fischer JA, Born W (1999) An amylin receptor is revealed following cotransfection of a calcitonin receptor with receptor activity modifying proteins-1 or-3. Endocrinology 140(6): 2924-2927.
46. Ng G, Varghese G, Chung HT, Trogadis J, Seeman P, O'Dowd BF, George SR (1997) Resistance of the dopamine D2L receptor to desensitization accompanies the up-regulation of receptors on to the surface of Sf9 cells. Endocrinology 138: 4199-4206.
47. Olson R, Dulac C, Bjorkman PJ (2006) MHC homologs in the nervous system-they haven't lost their groove. Curr Opin Neurobiol 16: 351-357.
48. Oppermann M (2004) Chemokine receptor CCR5: insights into structure, function, and regulation. Cell Signal 16(11): 1201-1210.
49. Parent A, Laroche G, Hamelin E, Parent JL (2008) RACK1 regulates the cell surface expression of the G protein-coupled receptor for thromboxane A(2). Traffic 9(3): 394-407.
50. Pilch-Cooper HA, Sieg SF, Hope TJ, Koons A, Escola JM, Offord R, Veazey RS, Mosier DE, Clagett B, Medvik K, Jadlowsky JK, Chance MR, Kiselar JG, Hoxie JA, Collman RG, Riddick NE, Mercanti V, Hartley O, Lederman MM (2010) Circulating human CD4 and CD8 T cells do not have large intracellular pools of CCR5. Blood 118: 1015-1019.
51. Portalès P, Fabre S, Vincent T, Desmetz C, Réant B, Noël D, Clot J, Jorgensen C, Corbeau P (2009) Peripheral blood T4 cell surface CCR5 density as a marker of activity in rheumatoid arthritis treated with anti-CD20 monoclonal antibody. Immunology 128: e738-e745.
52. Raport CJ, Gosling J, Schweickart VL, Gray PW, Charo IF (1996) Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha. J Biol Chem 271(29): 17161-17166.
53. Rodrigues-Ferreira S, Di Tommaso A, Dimitrov A, Cazaubon S, Gruel N, Colasson H, Nicolas A, Chaverot N, Molinie V, Reyal F, Sigal-Zafrani B, Terris B, Delattre O, Radvanyi F, Perez F, Vincent-Salomon A, Nahmias C (2009) 8p22 MTUS1 gene product ATIP3 is a novel antimitotic protein underexpressed in invasive breast carcinoma of poor prognosis. PLoS One 4(10): e7239.
54. Romero G, von Zastrow M, Friedman PA (2011) Role of PDZ proteins in regulating trafficking, signaling, and function of GPCRs: means, motif, and opportunity. Adv Pharmacol 62: 279-314.
55. Saito H, Kubota M, Roberts RW, Chi Q, Matsunami H (2004) RTP family members induce functional expression of mammalian odorant receptors. Cell 119(5): 679-691.
56. Schoneberg T, Yun J, Wenkert D, Wess J (1996) Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide. EMBO J 15: 1283-1291.
57. Sebag JA, Hinkle PM (2007) Melanocortin-2 receptor accessory protein MRAP forms antiparallel homodimers. Proc Natl Acad Sci U S A 104(51): 20244-20249.
58. Sebag JA, Hinkle PM (2009) Opposite effects of the melanocortin-2 (MC2) receptor accessory protein MRAP on MC2 and MC5 receptor dimerization and trafficking. J Biol Chem 284(34): 22641-22648.
59. Shioda T, Nakayama EE, Tanaka Y, Xin X, Liu H, Kawana-Tachikawa A, Kato A, Sakai Y, Nagai Y, Iwamoto A (2001) Naturally occurring deletional mutation in the C-terminal cytoplasmic tail of CCR5 affects surface trafficking of CCR5. J Virol 75(7): 3462-3468.
60. Shirvani H, Achour L, Scott MGH, Thuret A, Bismuth G, Labbe-Juillie C, Marullo S (2011) Internal stores of CCR5 in blood cells. Blood 118: 1175-1176.
61. Svenningsson P, Chergui K, Rachleff I, Flajolet M, Zhang X, El Yacoubi M, Vaugeois JM, Nomikos GG, Greengard P (2006) Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 311(5757): 77-80.
62. Wang G, Wu G (2012) Small GTPase regulation of GPCR anterograde trafficking. Trends Pharmacol Sci 33(1): 28-34.
63. White JH, Wise A, Main MJ, Green A, Fraser NJ, Disney GH, Barnes AA, Emson P, Foord SM, Marshall FH (1998) Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature 396(6712): 679-682.
64. Wruck CJ, Funke-Kaiser H, Pufe T, Kusserow H, Menk M, Schefe JH, Kruse ML, Stoll M, Unger T (2005) Regulation of transport of the angiotensin AT2 receptor by a novel membrane-associated Golgi protein. Arterioscler Thromb Vasc Biol 25(1): 57-64.
65. Yamamoto A, Nagano T, Takehara S, Hibi M, Aizawa S (2005) Shisa promotes head formation through the inhibition of receptor protein maturation for the caudalizing factors, Wnt and FGF. Cell 120(2): 223-235.
66. Yu R, Hinkle PM (1997) Effect of cell type on the subcellular localization of the thyrotropinreleasing hormone receptor. Mol Pharmacol 51: 785-793.
67. Zuchner S, Wang G, Tran-Viet KN, Nance MA, Gaskell PC, Vance JM, Ashley-Koch AE, Pericak-Vance MA (2006) Mutations in the novel mitochondrial protein REEP1 cause hereditary spastic paraplegia type 31. Am J Hum Genet 79(2): 365-369.